The deal will hand Novartis exposure to Chinook’s pipeline for kidney disease treatments.
You are here: Home / Top Stories / Dow Jones Newswires: Novartis agrees to buy Chinook Therapeutics for up to $3.5 billion
Market News and Views
The deal will hand Novartis exposure to Chinook’s pipeline for kidney disease treatments.